The Congressional Research Service continues to devote substantial attention to the nomination of Judge Merrick Garland to the Supreme Court, even if the U.S. Senate remains unwilling or unable to act on the nomination. This week CRS issued a new report presenting an annotated tabulation of hundreds of decisions written by Judge Garland.
“To assist Members and committees of Congress and their staff in their ongoing research into Judge Garland’s approach to the law, this report identifies and briefly summarizes each of the more than 350 cases in which Judge Garland has authored a majority, concurring, or dissenting opinion. Arguably, these written opinions provide the greatest insight into Judge Garland’s judicial approach, as a judge’s vote in a case or decision to join an opinion authored by a colleague may be based upon a number of considerations and may not necessarily represent full agreement with a joined opinion.”
See Majority, Concurring, and Dissenting Opinions Authored by Judge Merrick Garland, May 2, 2016. (The larger implications of Judge Garland’s opinions were analyzed in a separate CRS report that was issued last week.)
Other new and updated reports from the Congressional Research Service include the following.
China’s Natural Gas: Uncertainty for Markets, May 2, 2016
Synthetic Drugs: Overview and Issues for Congress, updated May 3, 2016
Funding of Presidential Nominating Conventions: An Overview, updated May 4, 2016
Green Infrastructure and Issues in Managing Urban Stormwater, updated May 2, 2016
DHS Budget v. DHS Appropriations: Fact Sheet, May 2, 2016
Overview of Commercial (Depository) Banking and Industry Conditions, May 3, 2016
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.